Recent Finacing
Recent Raise
Proclara Biosciences is a clinical-stage biotech developing GAIM platform fusion-protein therapeutics that target multiple misfolded proteins, advancing lead candidate NPT088 for Alzheimer’s and programs in neurodegenerative and systemic amyloidoses.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors